These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38736621)

  • 21. Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis.
    Song K; Hao J; Ge Z; Chen P
    J Oncol; 2020; 2020():3761535. PubMed ID: 32104175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
    Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
    J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CK14 Expression Identifies a Basal/Squamous-Like Type of Papillary Non-Muscle-Invasive Upper Tract Urothelial Carcinoma.
    Jung M; Jang I; Kim K; Moon KC
    Front Oncol; 2020; 10():623. PubMed ID: 32391279
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
    Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
    BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma.
    Bao Z; Zhan Y; He S; Li Y; Guan B; He Q; Yang X; Li X; Fang D; Zhou L
    Cancer Manag Res; 2019; 11():9095-9106. PubMed ID: 31695499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma.
    Zhang J; Chang DY; Mercado-Uribe I; Liu J
    Hum Pathol; 2012 Sep; 43(9):1405-12. PubMed ID: 22401770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
    Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D
    Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of B-lymphoma Moloney murine leukemia virus insertion region-1 and sex-determining region of Y chromosome-related high mobility group box-2 in cervical carcinogenesis.
    Xu R; Yang WT; Zheng PS
    Hum Pathol; 2013 Feb; 44(2):208-17. PubMed ID: 22863087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
    Warrick JI; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff D; Chen G
    Virchows Arch; 2017 Sep; 471(3):337-345. PubMed ID: 28721490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
    Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
    Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.
    Stoehr R; Wissmann C; Suzuki H; Knuechel R; Krieg RC; Klopocki E; Dahl E; Wild P; Blaszyk H; Sauter G; Simon R; Schmitt R; Zaak D; Hofstaedter F; Rosenthal A; Baylin SB; Pilarsky C; Hartmann A
    Lab Invest; 2004 Apr; 84(4):465-78. PubMed ID: 14968126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.
    Hua X; Huang M; Deng X; Xu J; Luo Y; Xie Q; Xu J; Tian Z; Li J; Zhu J; Huang C; Zhao QS; Huang H; Huang C
    Cell Death Differ; 2020 Feb; 27(2):632-645. PubMed ID: 31243344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of sex determining region Y-box 2, E-cadherin, and vimentin in esophageal squamous cell carcinoma.
    Li C; Ma YQ
    World J Clin Cases; 2022 Sep; 10(27):9657-9669. PubMed ID: 36186174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between SOX2 and Survivin clinical features in patients with salivary adenoid cystic carcinoma.
    Luo Y; Liu T; Fei W; Yue XG
    J Infect Public Health; 2019; 12(6):847-853. PubMed ID: 31113740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.
    Hoffman-Censits JH; Lombardo KA; Parimi V; Kamanda S; Choi W; Hahn NM; McConkey DJ; McGuire BM; Bivalacqua TJ; Kates M; Matoso A
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):619-625. PubMed ID: 33901032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
    Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
    Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.